PEER REVIEWED LITERATURE
Articles showing no adverse events when patients use cannabis in addition to opioids for pain management. Studies universally found that patients can decrease their opioid dose and have improved pain management, greater patient satisfaction and less side effects from opioids.
Abstract This is a 2015 study out of Canada, published in The Journal of Pain by the American Pain Society. It was a prospective cohort study. They gave cannabis to patients for 1 year with a matched control being patients …read more»
Abstract This is a review paper published in the Journal of Psychoactive Drugs in 2012. It’s a great summary article whose findings include: “When used in conjunction with opiates, cannabis provides a greater cumulative relief of pain, resulting in a …read more»
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study
Abstract This is a 2016 study that was a collaboration between the Washington University School of Medicine, The Hadassah-Hebrew University Medical Center published in the Clinical Journal of Pain. Findings included: “the treatment of chronic pain with medicinal cannabis…resulted in …read more»
Articles showing a 25-33% reduction in opioid overdose deaths in states with medical cannabis laws.
July, 2015 “Overall we find strong consistent evidence that medical marijuana dispensaries lead to reductions in opioid-related mortality.” Abstract “Many medical marijuana patients report using marijuana to alleviate chronic pain from musculoskeletal problems and other sources. If marijuana is used …read more»
August 25, 2014 Abstract A study published in the prestigious Journal of the American Medical Association in 2014 found that in states with Medical Marijuana programs there was an almost 25% reduction in opioid overdose deaths when compared with states …read more»
Study series showing that CBD can prevent cravings, which is important because cravings are the number one predictor of relapse
Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin-seeking and normalizes discrete mesolimbic neuronal disturbances
Abstract This study was published by the National Institutes of Health in 2009. The research was a collaboration between Mount Sinai Hospital in New York and the University Nacional de Educacion a Distancia in Madrid, Spain. It was an experimental …read more»
Cannabidiol: Swinging the Marijuana Pendulum From ‘Weed’ to Medication to Treat the Opioid Epidemic.
March, 2017 Abstract This is a great review written by Yasmin Hurd where she reviews her research (at Mount Sinai) on the effect CBD can have on opioid cravings during the withdrawal period. Her study started with a mouse model …read more»